Johnson & Johnson (JNJ) Meets EPS Estimate, Beats on Revenue; Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- AI bubble about to burst? Not yet, Yardeni says
- SpaceX tops Q3 estimates as revenue surges 161% on Starlink, AI compute expansion
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $255.14 -1.63%
Financial Fact:
Restructuring expense: 62M
Today's EPS Names:
OMID, BCML, CZNC, More
Financial Fact:
Restructuring expense: 62M
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
(Updated - January 21, 2026 8:28 AM EST)
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.46, in line with the analyst estimate of $2.46. Revenue for the quarter came in at $24.6 billion versus the consensus estimate of $24.15 billion.
GUIDANCE:
Johnson & Johnson sees FY2026 EPS of $11.43-$11.63, versus the consensus of $11.49. Johnson & Johnson sees FY2026 revenue of $100-101 billion, versus the consensus of $98.9 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Putin's Aide Says War In Ukraine Moving Toward An End - Vesti
- Appian stock rises amid software sector rally
- Roivant Sciences climbs on positive uveitis trial data
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
